Fatty Liver News and Research

Latest Fatty Liver News and Research

NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

A screening test for non-alcoholic fatty liver disease (NAFLD)--a serious condition that may have lifelong health consequences--is recommended for all obese children aged nine to eleven years, according to clinical practice guidelines developed by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and published in the Journal of Pediatric Gastroenterology and Nutrition.

1 Dec 2016

New public-private partnership launches major health effort to reduce cancer in San Francisco

Cancer is the leading cause of death in San Francisco and costs patients, families and taxpayers hundreds of millions of dollars each year.

21 Nov 2016

Molecules team up to maintain healthy level of fat in liver, study finds

As obesity rates rise in the United States, so does the incidence of liver diseases.

18 Nov 2016

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found.

18 Nov 2016

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem’s unique and multifaceted mode of action.

15 Nov 2016

Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors may lower the risk of developing non-alcoholic fatty liver disease (NAFLD), according to research presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases.

11 Nov 2016

New wearable medical device may reduce visceral fat, improve blood glucose in diabetes patients

Although effective for the treatment of diabetes, exercise is sometimes difficult for overweight or elderly people.

11 Nov 2016

Researchers reveal bi-directional link between fatty liver disease and cardiovascular disease

For the first time, researchers have shown that a bi-directional relationship exists between fatty liver disease and cardiovascular disease. Fatty liver disease can lead to increased cardiovascular disease risk and vice versa.

10 Nov 2016

High-protein diets may help prevent chronic diseases by reducing liver fat

According to a new nutritional study conducted by the German Institute of Human Nutrition on individuals with type 2 diabetes, high-protein diets reduced liver fat by up to 48 percent within six weeks. It did not matter whether the diet was mainly based on plant or animal protein.

2 Nov 2016

Turning off TAZ protein in liver cells reverses fibrosis in mice

Scientists at Columbia University Medical Center have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease that can lead to liver failure.

27 Oct 2016

Scientists develop smart drug that safely removes fat from liver and blood vessels

Scientists from the Technical University of Munich and Helmholtz Zentrum München have developed a ‘smart’ drug that safely clears the liver of fat and prevents blood vessels from clogging up.

13 Oct 2016

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis.

13 Oct 2016

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.

12 Oct 2016

Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.

12 Oct 2016

Research findings provide new avenues to target virus infection

Viral infection is one of the leading medical challenges of the 21st Century, ranging from the Hepatitis C Virus (HCV) epidemic affecting 3% of the global population, to recent outbreaks of West Nile, Zika, and Ebola viruses.

12 Oct 2016

New non-invasive method could improve diagnosis of severe liver disease

A new non-invasive method of predicting the risk of developing a severe form of liver disease could ensure patients receive early and potentially life-saving medical intervention before irreversible damage is done.

6 Oct 2016

Scientists identify molecule in liver cells that regulates release of fats into the bloodstream

ETH researchers have discovered a molecule in liver cells that controls the release of fat into the bloodstream. This "lock keeper" is present in large quantities in overweight people and leads indirectly to vascular narrowing.

28 Sep 2016

New study highlights clinical and economic burden of NAFLD in the U.S. and Europe

Non-alcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, is increasing in prevalence and is currently estimated to affect approximately one-quarter of the general population.

27 Sep 2016

Study provides insights into how insulin resistance, diabetes begin

Does eating too much sugar cause type 2 diabetes? The answer may not be simple, but a study published Sept. 26 in the Journal of Clinical Investigation adds to growing research linking excessive sugar consumption -- specifically the sugar fructose -- to a rise in metabolic disease worldwide.

26 Sep 2016

Bile acid transporter inhibitors can prevent NASH in mice, study shows

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of Atlanta have shown.

21 Sep 2016

Fatty Liver News and Research

Latest Fatty Liver News and Research

NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

New public-private partnership launches major health effort to reduce cancer in San Francisco

Molecules team up to maintain healthy level of fat in liver, study finds

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Particular eating behaviors linked to lower odds of developing liver diseases

New wearable medical device may reduce visceral fat, improve blood glucose in diabetes patients

Researchers reveal bi-directional link between fatty liver disease and cardiovascular disease

High-protein diets may help prevent chronic diseases by reducing liver fat

Turning off TAZ protein in liver cells reverses fibrosis in mice

Scientists develop smart drug that safely removes fat from liver and blood vessels

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

Research findings provide new avenues to target virus infection

New non-invasive method could improve diagnosis of severe liver disease

Scientists identify molecule in liver cells that regulates release of fats into the bloodstream

New study highlights clinical and economic burden of NAFLD in the U.S. and Europe

Study provides insights into how insulin resistance, diabetes begin

Bile acid transporter inhibitors can prevent NASH in mice, study shows

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Fatty Liver News and Research

Latest Fatty Liver News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in